Contents

Symposium on Autism: neural basis and treatment possibilities, held at the Novartis Foundation, London, 18-20 June 2002

This symposium is based on a proposal made by Professor Sir Michael Rutter

Editors: Gregory Bock (Organizer) and Jamie Goode

Micheal Rutter 
Introduction: autism-the challenges ahead

Tony Charman 
Epidemiology and early identification of autism: research challenges and opportunities
Abstract
Discussion

Anthony Bailey and Jeremy Parr 
Implications of the broader phenotype for concepts of autism
Abstract
Discussion

G. Barnby and A. P. Monaco 
Strategies for autism candidate gene analysis
Abstract
Discussion

Susan E. Folstein, Michael Dowd, Raymond Mankoski and Ovsanna Tadevosyan 
How might genetic mechanisms operate in autism?
Abstract
Discussion

David Skuse 
X-linked genes and the neural basis of social cognition
Abstract
Discussion

Margaret L. Bauman and Thomas L. Kemper 
The neuropathology of the autism spectrum disorders: what have we learned?
Abstract
Discussion

W. Ian Lipkin and Mady Hornig 
Microbiology and immunology of autism spectrum disorders 
Abstract
Discussion

Chris Frith 
What do imaging studies tell us about the neural basis of autism?
Abstract
Discussion

David G. Amaral and Blythe A. Corbett 
The amygdala, autism and anxiety
Abstract
Discussion

Francesca Happé 
Cognition in autism: one deficit or many?
Abstract
Discussion

Dorothy V. M. Bishop 
Autism and specific language impairment: categorical distinction or continuum?
Abstract
Discussion

Jan K. Buitelaar 
Why have drug treatments been so disappointing?
Abstract
Discussion

Patricia Howlin 
Can early interventions alter the course of autism?
Abstract
Discussion

Geraldine Dawson and Kathleen Zanolli 
Early intervention and brain plasticity in autism
Abstract
Discussion

Final discussion

Michael Rutter 
Summing-up

Return to the catalogue
Details of how to order this book